Abstract
Peripheral neuropathy is frequent in spinocerebellar ataxia type 2 (SCA2), but the pattern and characteristics of nerve involvement are still an unsettled issue. This study aimed to evaluate the prevalence, extent, and distribution of nerve involvement in SCA2 patients through neurophysiological studies. Thirty-one SCA2 patients and 20 control subjects were enrolled in this study. All subjects were prospectively evaluated through electromyography, including nerve conduction, needle electromyography in proximal and distal muscles of the upper and lower limbs, and sural radial amplitude ratio (SRAR). We aimed to differentiate distal axonopathy from diffuse nerve commitment, characterizing neuronopathy. Nerve involvement was observed in 83.6 % (26 individuals) of SCA2 patients. Among these, 19 had diffuse sensory abnormalities on nerve conduction predominantly on the upper limbs, with diffuse chronic denervation on needle electromyography and elevated SRAR values. Four individuals had only diffuse sensory involvement, and 2 had only motor involvement on needle evaluation and normal nerve conduction. These were interpreted as neuronopathy due to the diffuse distribution of the involvement. One individual had distal sensory axonopathy, with lower limb predominance. In this study, we found neuronopathy as the main pattern of nerve involvement in SCA2 patients and that motor involvement is a frequent feature. This information brings new insights into the understanding of the pathophysiology of nerve involvement in SCA2 and sets some key points about the phenotype, which is relevant to guide the genetic/molecular diagnosis.
Similar content being viewed by others
References
Schöls L, Bauer P, Schmidt T, Schulte T, Riess O. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet. 2004;3:291–304.
Lastres-Becker I, Rüb U, Auburger G. Spinocerebellar ataxia 2 (SCA2). Cerebellum. 2008;7:115–24.
Velázquez-Perez L, Rodriguez-Labrada R, Garcia Rodriguez JC, Almaguer-Mederos LE, Cruz-Marino T, Laffita-Mesa JM. A comprehensive review of spinocerebellar ataxia type 2 in Cuba. Cerebellum. 2011;10:184–98.
Wadia NH, Swami RK. A new form of heredo-familial spinocerebellar degeneration with slow eye movements (nine families). Brain. 1971;94:359–74.
Schols L, Linnemann C, Globas C. Electrophysiology in spinocerebellar ataxias: spread of disease and characteristic findings. Cerebellum. 2008;7(2):198–203.
Pedroso JL, Bezerra ML, Braga-Neto P, Pinheiro DS, Minett T, do Prado GF, et al. Is neuropathy involved with restless legs syndrome in Machado Joseph disease? Eur Neurol. 2011;66:200–3.
Escorcio Bezerra ML Pedroso JL, Pinheiro DS, Braga-Neto P, Povoas B, Braga NI, et al. Pattern of peripheral nerve involvement in Machado-Joseph disease: neuronopathy or distal axonopathy? A clinical and neurophysiological evaluation. Eur Neurol. 2013;69:129–33.
Abele M, Burk K, Andres F, Topka H, Laccone F, Bosch S, et al. Autosomal dominant cerebellar ataxia type. Nerve conduction and evoked potential studies in families with SCA1, SCA2 and SCA3. Brain. 1997;120:2141–8.
Kubis N, Du’rr A, Gugenheim M, Chneiweiss H, Mazzetti P, Brice A, et al. Polyneuropathy in autossomal dominant cerebellar ataxias: phenotype-genotype correlation. Muscle Nerve. 1999;22:712–7.
Yadav R, Pal PK, Krishna N, Amar BR, Jain S, Purushottam M. Electrophysiological evaluation of spinocerebellar ataxias 1, 2 and 3. J Neurol Sci. 2012;312:142–5.
Álvarez-Paradelo S, García A, Infante J, Berciano J. Multimodal neurophysiological study of SCA2 and SCA3 autosomal dominant hereditary spinocerebellar ataxias. Neurologia. 2011;26:157–65.
van de Warrenburg BP, Notermans NC, Schelhaas HJ, van Alfen N, Sinke RJ, Knoers NV, et al. Peripheral nerve involvement in spinocerebellar ataxias. Arch Neurol. 2004;61:257–61.
Linnemann C, Tezenas du Montcel S, Rakowicz M, Schmitz-Hübsch T, Szymanski S,Berciano J, van de Warrenburg BP, Pedersen K, Depondt C, Rola R, Klockgether T,García A, Mutlu G, Schöls L. Peripheral neuropathy in spinocerebellar ataxia type 1, 2, 3, and 6. Cerebellum. 2015.
Crum BA, Joseph KA. Varied electrophysiologic patterns in spinocerebellar ataxia type 2. Eur J Neurol. 2006;13:194–7.
Braga-Neto P, Pedroso JL, Felício AC, Abrahão A, Dutra LA, Bezerra ML, et al. SCA2 presenting as an ataxia-parkinsonism-motor neuron disease syndrome. Arq Neuropsiquiatr. 2011;69:405–6.
Nanetti L, Fancellu R, Tomasello C, Gellera C, Pareyson D, Mariotti C. Rare association of motor neuron disease and spinocerebellar ataxia type 2 (SCA2): a new case and review of the literature. J Neurol. 2009;256:1926–8.
Braga-Neto P, Godeiro-Junior C, Dutra LA, Pedroso JL, Barsottini OG. Translation and validation into Brazilian version of the Scale of the Assessment and Rating of Ataxia (SARA). Arq Neuropsiquiatr. 2010;68:228–30.
de Castilhos RM, Furtado GV, Gheno TC, Schaeffer P, Russo A, Barsottini O, et al. Spinocerebellar ataxias in Brazil—frequencies and modulating effects of related genes. 2014;13(1):17.
Nobrega JA, Pinheiro DS, Manzano GM, Kimura J. Various aspects of F-wave values in a healthy population. Clin Neurophysiol. 2004;115:2336–42.
England JD, Gronseth GS, Franklin G, Miller RG, Asbury AK, Carter GT, et al. Distal symmetric polyneuropathy: a definition for clinical research. Neurology. 2005;64:199–207.
Esper GJ, Nardin RA, Benatar M, Sax TW, Acosta JA, Raynor EM. Sural and radial sensory responses in healthy adults: diagnostic implications for polyneuropathy. Muscle Nerve. 2005;31:628–32.
Rutkove SB, Kothari MJ, Raynor EM, Levy ML, Fadic R, Nardin RA. Sural/radial amplitude ratio in the diagnosis of mild axonal polyneuropathy. Muscle Nerve. 1997;20:1236–41.
França Jr MC, D’abreu A, Nucci A, Cendes F, Lopes-Cendes I. Prospective study of peripheral neuropathy in Machado-Joseph disease. Muscle Nerve. 2009;40:1012–8.
Velázquez-Pérez L, Cruz GS, Ochoa NC, Labrada RR, Díaz JR, Mederos LA, et al. Electrophysiological features in patients and presymptomatic relatives with spinocerebellar ataxia type 2. J Neurol Sci. 2007;263:158–64.
Huynh DP, Del Bigio MR, Ho DH, Pulst SM. Expression of ataxin-2 in brains from normal individuals and patients with Alzheimer’s disease and spinocerebellar ataxia 2. Ann Neurol. 1999;45:232–41.
Robitaille Y, Lopes-Cendes I, Becher M, Rouleau G, Clark AW. The neuropathology of CAG repeat diseases: review and update of genetic and molecular features. Brain Pathol. 1997;7:901–26.
Estrada R, Galarraga J, Orozco G, Nodarse A, Auburger G. Spinocerebellar ataxia 2 (SCA2): morphometric analyses in 11 autopsies. Acta Neuropathol. 1999;97:306–10.
Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010;466:1069–75.
Baumer D, East SZ, Tseu B, Zeman A, Hilton TK, et al. FTLD-ALS of TDP-43 type and SCA2 in a family with a full ataxin-2 polyglutamine expansion. Acta Neuropathol. 2014;128:597–604.
Pinto S, De Carvalho M. Machado-Joseph disease presenting as motor neuron disease. Amyotroph Lateral Scler. 2008;9:188–91.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interests
We have no conflict of interest.
Financial Disclosure
We have nothing to disclose.
Ethical Statement
Full consent was obtained from the patients to be enrolled in this study. Our Institutional Research Ethics Board approved this study.
Rights and permissions
About this article
Cite this article
Bezerra, M.L.E., Pedroso, J.L., Braga-Neto, P. et al. Pattern of Peripheral Nerve Involvement in Spinocerebellar Ataxia Type 2: a Neurophysiological Assessment. Cerebellum 15, 767–773 (2016). https://doi.org/10.1007/s12311-015-0753-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12311-015-0753-x